Skip to content

Dimer Instruments

Light-scattering instruments for protein stability analysis

Raised to date

$11M

of $11M offered across 1 Form D filing

Investors
1
Last filed
Jul 24, 2026

About

Dimer Instruments is a Santa Barbara, California company building analytical instrumentation for the biopharmaceutical industry. Founded in 2023 by Dr. Stephen Minne and Dr. Michael Larkin, both veterans of light-scattering instrument maker Wyatt Technology, it applies multi-angle and dynamic light scattering (MALS and DLS) and biophysical characterization to drug discovery, formulation, and manufacturing. Its instruments measure protein stability, molecular binding interactions, and protein expression, including process analytical technology (PAT) applications for real-time monitoring during manufacturing.

Founded by light-scattering instrumentation veterans, the company targets real-time, in-process biophysical measurement (PAT) rather than offline benchtop-only analysis, aiming to move protein characterization onto the manufacturing line.

Funding

  • EquityFiled Jul 24, 2026Form D/A
    $11M/ $11M

Product

Biophysical characterization instruments

Scientific and analytical instrumentation

A line of light-scattering and biophysical analysis instruments for biopharma R&D and manufacturing, measuring protein conformational and colloidal stability, binding affinity, and expression levels, with process analytical technology applications for real-time quality monitoring.

  • Multi-angle light scattering (MALS) and dynamic light scattering (DLS) measurement
  • Conformational and colloidal protein stability in a single experiment
  • Binding affinity measurement in solution with low sample consumption

Built for

Pharmaceutical and biopharmaceutical companies doing protein therapeutic discovery, formulation, and manufacturing, plus their analytical development and process teams

People on file